G. Ardine de Wit

researcher ORCID ID = 0000-0002-1375-7657

G. Ardine de Wit is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-1375-7657
P1153Scopus author ID7004309515

P69educated atErasmus University RotterdamQ633529
Maastricht UniversityQ1137652
P108employerErasmus University RotterdamQ633529
Netherlands National Institute for Public Health and the EnvironmentQ1055186
Free University of AmsterdamQ1065414
Maastricht UniversityQ1137652
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q46930034A composite score of protein-energy nutritional status predicts mortality in haemodialysis patients no better than its individual components.
Q36044524A systematic review of financial incentives given in the healthcare setting; do they effectively improve physical activity levels?
Q39049389Age-specific Incidence and Prevalence of Keratoconus: A Nationwide Registration Study.
Q48638635An alternative approach identified optimal risk thresholds for treatment indication: an illustration in coronary heart disease.
Q71879488An appraisal of living donor kidney transplantation
Q79765860Assessing the introduction of universal varicella vaccination in the Netherlands
Q30371888CINGLE-trial: cochlear implantation for siNGLE-sided deafness, a randomised controlled trial and economic evaluation.
Q45030516Changes in quality of life over time--Dutch haemodialysis patients and general population compared.
Q37841524Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands.
Q48505301Clinical performance targets and quality of life in hemodialysis patients.
Q42355392Comment on 'Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS'.
Q47572168Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study.
Q35177209Consistency between stated and revealed preferences: a discrete choice experiment and a behavioural experiment on vaccination behaviour compared
Q93194118Consumers' preferences for freezing of meat to prevent toxoplasmosis- A stated preference approach
Q36480971Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.
Q38770170Cost-Effectiveness Analysis of Corneal Collagen Crosslinking for Progressive Keratoconus.
Q36155257Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands
Q50147730Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
Q90633616Cost-effectiveness analysis of a multicentre randomized clinical trial comparing surgery with conservative management for recurrent and ongoing diverticulitis (DIRECT trial)
Q37704152Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study
Q35640489Cost-effectiveness of a nurse-led internet-based vascular risk factor management programme: economic evaluation alongside a randomised controlled clinical trial
Q36571135Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
Q58588346Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country
Q44559093Cost-effectiveness of treatment of acute otorrhea in children with tympanostomy tubes
Q31134164Cost-utility analysis to control Campylobacter on chicken meat: dealing with data limitations.
Q60624527Costs and Effects of Prenatal Screening Methods for Down Syndrome and Neural Tube Defects
Q36093560Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: a prospective multicenter study
Q33651562DIRECT trial. Diverticulitis recurrences or continuing symptoms: Operative versus conservative treatment. A multicenter randomised clinical trial.
Q67834673Diffusion of in-vitro fertilization in The Netherlands and England. An exploratory study
Q74794865Diffusion of in-vitro fertilization in the Netherlands and England: an exploratory study
Q34872562Disability weights for comorbidity and their influence on health-adjusted life expectancy
Q33361189Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157.
Q40597614Does disease activity add to functional disability in estimation of utility for rheumatoid arthritis patients on biologic treatment?
Q79186802Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam study
Q39668525Dutch Tariff for the Five-Level Version of EQ-5D.
Q36750107Economic evaluations of cholesterol-lowering drugs: a critical and systematic review.
Q36492511Effect of hemodiafiltration on quality of life over time.
Q58892269Effectiveness and Efficiency of Controlling Campylobacter on Broiler Chicken Meat
Q43646285Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).
Q34714144Effectiveness and cost-effectiveness of an injury prevention programme for adult male amateur soccer players: design of a cluster-randomised controlled trial.
Q57801379Effectiveness of diabetes self-management education via a smartphone application in insulin treated type 2 diabetes patients - design of a randomised controlled trial ('TRIGGER study')
Q34634196Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates.
Q46716198Erratum to: Differences in quality of life of hemodialysis patients between dialysis centers.
Q42363418Erratum to: Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
Q35131146Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.
Q117800328Estimating the health impact of delayed elective care during the COVID -19 pandemic in the Netherlands
Q35690039Exploring Outcomes to Consider in Economic Evaluations of Health Promotion Programs: What Broader Non-Health Outcomes Matter Most?
Q27314819Exploring how individuals complete the choice tasks in a discrete choice experiment: an interview study
Q90613732Fast-track Radioiodine Ablation Therapy After Thyroidectomy Reduces Sick Leave in Patients With Differentiated Thyroid Cancer (FASTHYNA Trial)
Q53458689Health profiles and health preferences of dialysis patients.
Q36121879Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study
Q38676867Impact of Survey Administration Mode on the Results of a Health-Related Discrete Choice Experiment: Online and Paper Comparison
Q42226623Influence of early goal-directed therapy using arterial waveform analysis on major complications after high-risk abdominal surgery: study protocol for a multicenter randomized controlled superiority trial.
Q36028668Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial
Q47317898Long-term outcomes and cost effectiveness of high-dose dexamethasone for cardiac surgery: a randomised trial.
Q51857756Model based analysis of hepatitis B vaccination strategies in the Netherlands.
Q58733082Optimising pain management in children with acute otitis media through a primary care-based multifaceted educational intervention: study protocol for a cluster randomised controlled trial
Q41070159Patient selection for cardiac surgery: Time to consider subgroups within risk categories?
Q39067752Personal health records in the Netherlands: potential user preferences quantified by a discrete choice experiment.
Q33599364Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial
Q47675856Predicted burden could replace predicted risk in preventive strategies for cardiovascular disease.
Q86068756Preferences for Vaccination: Does Health Literacy Make a Difference?
Q45324400Preventive exercises reduced injury-related costs among adult male amateur soccer players: a cluster-randomised trial.
Q48716376Protein-energy nutritional status and kidney disease-specific quality of life in hemodialysis patients.
Q37572143Quality of life in community-dwelling Dutch elderly measured by EQ-5D-3L.
Q28750329Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA
Q90663023Ranking Preventive Interventions from Different Policy Domains: What Are the Most Cost-Effective Ways to Improve Public Health?
Q61058317Rapid diagnostic testing of methicillin-resistant Staphylococcus aureus carriage at different anatomical sites: costs and benefits of less extensive screening regimens
Q54437707Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.
Q35071890Rationale and design of the costs, health status and outcomes in community-acquired pneumonia (CHO-CAP) study in elderly persons hospitalized with CAP
Q36730251Selective decontamination of the digestive tract and selective oropharyngeal decontamination in intensive care unit patients: a cost-effectiveness analysis.
Q60629840Sensitivity and perspective in the valuation of health status: whose values count?
Q36388093Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.
Q38464443Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis.
Q39883417Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
Q39241076Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models: Stop Developing, Start Evaluating
Q35013380Tailoring the implementation of new biomarkers based on their added predictive value in subgroups of individuals
Q38686325Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
Q40828696The burden of Lyme borreliosis expressed in disability-adjusted life years
Q33387950The cost-effectiveness of increasing alcohol taxes: a modelling study.
Q43167588The design of a Social Cost-Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approach
Q39193922The economic burden of a Salmonella Thompson outbreak caused by smoked salmon in the Netherlands, 2012-2013.
Q34445812The effect of including an opt-out option in discrete choice experiments
Q34130122The effect of out-of-pocket costs and financial rewards in a discrete choice experiment: an application to lifestyle programs
Q46469044The effect of renal denervation added to standard pharmacologic treatment versus standard pharmacologic treatment alone in patients with resistant hypertension: rationale and design of the SYMPATHY trial.
Q34505429The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
Q36307771The impact of community-acquired pneumonia on the health-related quality-of-life in elderly
Q35753875The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population.
Q38997255The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases
Q35056770Type 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experiment
Q40921728Ultra low-dose chest ct with iterative reconstructions as an alternative to conventional chest x-ray prior to heart surgery (CRICKET study): Rationale and design of a multicenter randomized trial
Q80553568Universal hepatitis B vaccination
Q57418010Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratio
Q35686520Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review
Q89871896Valuing Healthcare Goods and Services: A Systematic Review and Meta-Analysis on the WTA-WTP Disparity
Q44277873What Are the Costs of Corneal Cross-linking for the Treatment of Progressive Keratoconus?
Q35555621Willingness to participate in a lifestyle intervention program of patients with type 2 diabetes mellitus: a conjoint analysis.
Q38990760Words or graphics to present a Discrete Choice Experiment: Does it matter?

Search more.